MA27850A1 - Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate - Google Patents

Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate

Info

Publication number
MA27850A1
MA27850A1 MA28647A MA28647A MA27850A1 MA 27850 A1 MA27850 A1 MA 27850A1 MA 28647 A MA28647 A MA 28647A MA 28647 A MA28647 A MA 28647A MA 27850 A1 MA27850 A1 MA 27850A1
Authority
MA
Morocco
Prior art keywords
clavulanate
preparations containing
pharmaceutical preparations
containing amoxicillin
amoxicillin
Prior art date
Application number
MA28647A
Other languages
English (en)
Inventor
Michael Gale Ramsey
Jill Tracy Rickman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0313913.6A external-priority patent/GB0313913D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA27850A1 publication Critical patent/MA27850A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des préparations contenant de l'amoxicilline et du clavulanate, destinées à être reconstituées en suspension aqueuse. Ces préparations contiennent de faibles concentrations de carboxyméthylcellulose pouvant stabiliser leur pH.
MA28647A 2003-06-16 2005-12-09 Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate MA27850A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47876903P 2003-06-16 2003-06-16
GBGB0313913.6A GB0313913D0 (en) 2003-06-16 2003-06-16 New use

Publications (1)

Publication Number Publication Date
MA27850A1 true MA27850A1 (fr) 2006-04-03

Family

ID=33420899

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28647A MA27850A1 (fr) 2003-06-16 2005-12-09 Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate

Country Status (13)

Country Link
EP (1) EP1491195A1 (fr)
JP (1) JP2006527726A (fr)
KR (1) KR20060010838A (fr)
AU (1) AU2004246811A1 (fr)
BR (1) BRPI0411524A (fr)
CA (1) CA2529102A1 (fr)
CO (1) CO5640085A2 (fr)
IL (1) IL172096A0 (fr)
MA (1) MA27850A1 (fr)
MX (1) MXPA05013433A (fr)
NO (1) NO20055882L (fr)
RU (1) RU2343931C2 (fr)
WO (1) WO2004110441A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007002924A1 (de) * 2007-01-19 2008-07-24 Bayer Healthcare Ag ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung
EP2802327A1 (fr) * 2012-01-10 2014-11-19 Michael Spector Formulations de suspension orale pédiatrique d'amoxicilline et de clavulanate de potassium et leur procédé d'utilisation
CN114668724B (zh) * 2020-12-24 2023-08-22 鲁南制药集团股份有限公司 一种阿莫西林克拉维酸钾干混悬剂及其制备方法
CN114886893B (zh) * 2021-07-30 2023-09-29 江苏恒丰强生物技术有限公司 一种复方阿莫西林粉及其制备方法
CN116327760A (zh) * 2022-12-26 2023-06-27 南京臣功制药股份有限公司 一种阿莫西林克拉维酸钾缓释干混悬剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201468T3 (es) * 1997-02-14 2004-03-16 Laboratoire Glaxosmithkline S.A.S. Preparacion farmaceutica que comprende amoxicilina y clavulanato.
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
AU6571400A (en) * 1999-08-20 2001-03-19 Smithkline Beecham Laboratoires Pharmaceutiques S.A.S. Pharmaceutical formulation comprising amoxycillin and clavulanate

Also Published As

Publication number Publication date
RU2343931C2 (ru) 2009-01-20
IL172096A0 (en) 2009-02-11
BRPI0411524A (pt) 2006-08-01
CO5640085A2 (es) 2006-05-31
MXPA05013433A (es) 2006-03-09
JP2006527726A (ja) 2006-12-07
WO2004110441A8 (fr) 2005-03-17
EP1491195A1 (fr) 2004-12-29
CA2529102A1 (fr) 2004-12-23
NO20055882L (no) 2005-12-28
AU2004246811A1 (en) 2004-12-23
RU2005138127A (ru) 2006-07-27
WO2004110441A1 (fr) 2004-12-23
KR20060010838A (ko) 2006-02-02

Similar Documents

Publication Publication Date Title
IS7984A (is) Palonsetron lyfjasamsetningar á vökvaformi
HUP0302021A2 (hu) Szteroid tartalmú stabilizált vizes szuszpenziók parenterális használathoz
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
MY153718A (en) Formulation of human antibodies for treating tnf-(?) associated disorders
DK1809237T3 (da) Ophthalmisk olie-i-vand emulsion med stabilt positivt zeta-potentiale
ECSP044974A (es) Formulación de suspensión oral estabilizada
AR029288A1 (es) Derivados de 1-sulfonil-pirrolidina
PT941095E (pt) Composicoes farmaceuticas melhoradas
HUP0203773A2 (hu) Epinastintartalmú oldatok
AR038947A1 (es) Suspension oral de sabor agradable y metodo
MA27850A1 (fr) Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate
TNSN00235A1 (fr) Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
DE69905878D1 (de) Zubereitungen enthaltend sclareol und sclareolide zur behandlung mikrobieller infektionen
NO20054662L (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE60117248D1 (de) Parenterale lösung enthaltend amiodaron
WO2004069187A3 (fr) Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees
ATE352287T1 (de) Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines